BioWorld MedTech

Feb. 23, 2015

View Archived Issues

PwC report points out change in industry/FDA relationship

Inside the Beltway: Litwack says biggest concern for NGS is specific intended use

Financings: Saluda gets $10 million in new B round for chronic pain research

MDD Stock Report winners and losers

MDD Stock Report for Public Med-tech Companies

23andMe wins DTC approval for Bloom Syndrome genetic test

HIT Bits HIT Bits: Resolute H:ealth Hospital achieves HIMSS Analytics Stage 6 status

Restructuring: Integra Lifesciences cut 49 positions in Massachusetts facility late last year

Products

People in Places

MDD's Neurology Extra

Medtronic publishes five-year results from SANTE trial for DBS in epilepsy

Five-year results from a clinical study evaluating the use of deep brain stimulation (DBS) in adult epilepsy patients supports the use of DBS for treatment-resistant (refractory) epilepsy. Read More

Perspectives Blog: Dam it: CMS plays the part of Hoover

Today's news in brief

BioWorld

BioWorld briefs for Jan 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 9, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

Development and characterization of anti-CD19 in vivo CAR T therapy

BioWorld Science

Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...

Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome

BioWorld Science

The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...